Xcopri 100 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F63V3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,141
Award facts
- Contract value 100% obligated
- $1,141.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,141.38 to AmerisourceBergen Drug Corp for XCOPRI 100 mg tablets (30-count packaging) on December 15, 2025, with an ultimate completion date of December 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. XCOPRI is a prescription medication used in the treatment of seizure disorders, reflecting the Defense Logistics Agency's continued procurement of specialized pharmaceutical products to support military healthcare systems.
This delivery order operates as a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp leverages this comprehensive IDC to supply an extensive range of pharmaceutical products, medical devices, and healthcare commodities to support military and veteran healthcare programs globally. The contract vehicle enables the company to serve multiple federal customers including the Defense Health Agency and U.S. Coast Guard through flexible ordering mechanisms that accommodate diverse medical supply requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F63V3?
SPE2DR26F63V3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26F63V3 worth?
The government has obligated $1,141 on SPE2DR26F63V3.
Is contract SPE2DR26F63V3 an order under another contract?
Yes. SPE2DR26F63V3 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F63V3 competed?
The extent of competition for SPE2DR26F63V3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award